Summary of a consensus conference on heart-liver transplantation

Consensus Conference participants

Research output: Contribution to journalArticlepeer-review

Abstract

Patients with severe heart disease may have coexisting liver disease from various causes. The incidence of combined heart-liver transplant (CHLT) is increasing as more patients with congenital heart disease survive to adulthood and develop advanced heart failure with associated liver disease from chronic right-sided heart or Fontan failure. However, the criteria for CHLT have not been established. To address this unmet need, a virtual consensus conference was organized on June 10, 2022, endorsed by the American Society of Transplantation. The conference represented a collaborative effort by experts in cardiothoracic and liver transplantation from across the United States to assess interdisciplinary criteria for liver transplantation in the CHLT candidate, surgical considerations of CHLT, current allocation system that generally results in the liver following the heart for CHLT, and optimal post-CHLT management. The conference served as a forum to unify criteria between the different specialties and to forge a pathway for patients who may need dual organ transplantation. Due to the continuing shortage of available donor organs, ethical issues related to multiorgan transplantation were also debated. The findings and consensus statements are presented.

Original languageEnglish (US)
Pages (from-to)380-390
Number of pages11
JournalAmerican Journal of Transplantation
Volume24
Issue number3
DOIs
StatePublished - Mar 2024

Keywords

  • criteria
  • heart transplantation
  • liver transplantation
  • outcomes

ASJC Scopus subject areas

  • Transplantation
  • Pharmacology (medical)
  • Immunology and Allergy

Fingerprint

Dive into the research topics of 'Summary of a consensus conference on heart-liver transplantation'. Together they form a unique fingerprint.

Cite this